Affinity Asset Advisors’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 74 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 70 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 63 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 64 |
|
|
2022
Q4 | – | Sell |
-136,434
| Closed | -$2.15M | – | 55 |
|
|
2022
Q3 | $2.15M | Buy |
136,434
+36,434
| +36% | +$573K | 0.6% | 31 |
|
|
2022
Q2 | $1.4M | Hold |
100,000
| – | – | 0.59% | 24 |
|
|
2022
Q1 | $1.72M | Sell |
100,000
-300,000
| -75% | -$5.17M | 0.28% | 33 |
|
|
2021
Q4 | $5.82M | Buy |
400,000
+50,000
| +14% | +$727K | 2.11% | 15 |
|
|
2021
Q3 | $6.3M | Buy |
350,000
+75,000
| +27% | +$1.35M | 1.59% | 11 |
|
|
2021
Q2 | $4.83M | Buy |
275,000
+52,733
| +24% | +$926K | 1.73% | 15 |
|
|
2021
Q1 | $5.6M | Buy |
+222,267
| New | +$5.6M | 1.9% | 9 |
|